PET CONTRAST AGENT FOR INTERROGATING IMMUNODEFICIENCY VIRUS INFECTIONS
PET CONTRAST AGENT FOR INTERROGATING IMMUNODEFICIENCY VIRUS INFECTIONS
批准号:
8172483
负责人:
Eric Hunter
金额:
$5.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
Acquired Immunodeficiency SyndromeAffinityAntiviral AgentsBiological ModelsCell Culture TechniquesCellsComputer Retrieval of Information on Scientific Projects DatabaseContrast MediaDetectionDevelopmentDiagnosticFundingGrantHIV Envelope Protein gp120HIV InfectionsHalf-LifeHumanImageImmunoglobulin FragmentsImmunologic Deficiency SyndromesInfectionInfection preventionInstitutionKineticsLifeLigandsMacacaMacaca mulattaModelingPositron-Emission TomographyRadiolabeledResearchResearch PersonnelResourcesSIVScanningSourceSpecificityTimeUnited States National Institutes of HealthVaccinesVirus Diseasesin vivoradiotracerrecombinant peptidesimian immunodeficiency virus gp120
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
目前,还没有允许评估活体受试者内的免疫缺陷病毒感染的体内诊断剂或造影剂。 这种诊断将识别体内受感染的细胞,并提供一种非侵入性的方式来获得有关感染的时间过程信息。它对于评估疫苗预防感染或破坏体内受感染细胞的能力以及用于表征新抗病毒剂的功效和动力学将是非常宝贵的。 在这项资助中,我们提出了一种正电子发射断层扫描(PET)造影剂的发展,使用猴免疫缺陷病毒(SIV)感染的恒河猴作为我们的模型系统。 该模型系统目前产生的艾滋病毒感染和获得性免疫缺陷综合征(艾滋病)在人类中的最准确的表示。 我们的具体目标是:目的1)在细胞培养模型中开发抗SIV gp 120的高亲和力配体。 将优化和比较抗体片段、肽和重组CD 4,以找到对gp 120的最高亲和力和特异性配体。目的2)利用放射性标记探针对SIV感染猕猴的细胞进行成像。 将在感染过程中的不同日期将由高亲和力配体和64 Cu(12.7小时半衰期)(一种与PET成像相容的放射性标记)组成的放射性标记探针注射到感染的猕猴中,并进行成像以确定最小扫描时间和扫描程度,以最大限度地检测猕猴中的感染细胞。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Currently, there is no in-vivo diagnostic or contrast agent that allows the assessment of an immunodeficiency virus infection within a living subject. Such a diagnostic would identify infected cells within the body, and provide a non-invasive way of obtaining time-course information about the infection. It will be invaluable for assessing the ability of a vaccine to prevent infection or destroy infected cells within the body, as well as being useful for characterizing the efficacy and kinetics of new antiviral agents. In this grant, we are proposing the development of a positron emission tomography (PET) contrast agent using the simian immunodeficiency virus (SIV) infection of rhesus macaques as our model system. This model system currently yields the most accurate representation of an HIV infection and acquired immunodeficiency syndrome (AIDS) in humans. Our specific aims are: AIM 1) Develop a high affinity ligand against SIV gp120 in a cell culture model. Antibody fragments, peptides, and recombinant CD4 will be optimized and compared in order to find the highest affinity and specificity ligand for gp120. AIM 2) Image infected cells during time course of a SIV infection in live macaques using radiolabeled probe. Radiolabeled probes, composed of a high affinity ligand and 64Cu (12.7 hr half life), a radiolabel compatible with PET imaging, will be injected into infected macaques on different days during the time course of the infection and imaged to determine minimum scan time and extent of scan that can be performed to maximize our detection of infected cells within the macaques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the impact of sex in early subtype C HIV infection and during HART
-
批准号:10552412
-
项目类别:
-
资助金额:$86.43万
-
财政年份:2022
-
负责人:Eric Hunter
-
依托单位:
Deciphering the impact of sex in early subtype C HIV infection and during HART
-
批准号:10663367
-
项目类别:
-
资助金额:$84.88万
-
财政年份:2022
-
负责人:Eric Hunter
-
依托单位:
HIV Research for Prevention Conference combining AIDS Vaccine & Microbicides
-
批准号:8731587
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2014
-
负责人:Eric Hunter
-
依托单位:
Administrative
-
批准号:8516872
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2013
-
负责人:Eric Hunter
-
依托单位:
PET CONTRAST AGENT FOR INTERROGATING IMMUNODEFICIENCY VIRUS INFECTIONS
-
批准号:8357519
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Eric Hunter
-
依托单位:
VIROLOGIC CORRELATES OF HETEROSEXUAL TRANSMISSION
-
批准号:8357424
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Eric Hunter
-
依托单位:
GENETICS OF PRIMATE 'D' TYPE RETROVIRUSES
-
批准号:8357425
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Eric Hunter
-
依托单位:
CTL AND HIV POLYMORPHISMS IN HETEROSEXUAL TRANSMISSION
-
批准号:8357448
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Eric Hunter
-
依托单位:
Administrative
-
批准号:8326365
-
项目类别:
-
资助金额:$42.33万
-
财政年份:2011
-
负责人:Eric Hunter
-
依托单位:
STRUCTURE/FUNCTION ANALYSIS OF THE HIV ENV GENE PRODUCT
-
批准号:8172360
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:Eric Hunter
-
依托单位:
MOLECULAR ANALYSIS & MODELING OF HIV-1 TRANSMISSION, CONTAINMENT AND ESCAPE
-
批准号:8172395
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:Eric Hunter
-
依托单位:
VIROLOGIC CORRELATES OF HETEROSEXUAL TRANSMISSION
-
批准号:8172358
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:Eric Hunter
-
依托单位:
Virologic Correlates of Heterosexual Transmission
-
批准号:8070224
-
项目类别:
-
资助金额:$51.96万
-
财政年份:2010
-
负责人:Eric Hunter
-
依托单位:
GENETICS OF PRIMATE 'D' TYPE RETROVIRUSES
-
批准号:8172359
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:Eric Hunter
-
依托单位:
CTL AND HIV POLYMORPHISMS IN HETEROSEXUAL TRANSMISSION
-
批准号:8172394
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:Eric Hunter
-
依托单位:
VIROLOGIC CORRELATES OF HETEROSEXUAL TRANSMISSION
-
批准号:7958166
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:Eric Hunter
-
依托单位:
MOLECULAR ANALYSIS & MODELING OF HIV-1 TRANSMISSION, CONTAINMENT AND ESCAPE
-
批准号:7958218
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:Eric Hunter
-
依托单位:
GENETICS OF PRIMATE 'D' TYPE RETROVIRUSES
-
批准号:7958167
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:Eric Hunter
-
依托单位:
CTL AND HIV POLYMORPHISMS IN HETEROSEXUAL TRANSMISSION
-
批准号:7958217
-
项目类别:
-
资助金额:$5.67万
-
财政年份:2009
-
负责人:Eric Hunter
-
依托单位:
SIV TRANSMISSION BY LOW-DOSE VAGINAL INOCULATION OF RHESUS MACAQUES
-
批准号:7958382
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2009
-
负责人:Eric Hunter
-
依托单位:
海外基金